Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

NCR graphs - Incidence rates by year

- All cancer including non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer including non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- All cancer excluding non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer excluding non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Oesophagus cancer, crude incidence rate, males, 2005-2015
- Oesophagus cancer, crude incidence rate, females, 2005-2015

- Stomach cancer, crude incidence rate, males, 2005-2015
- Stomach cancer, crude incidence rate, females, 2005-2015

- Colo-rectal cancer, crude incidence rate, males, 2005-2015
- Colo-rectal cancer, crude incidence rate, females, 2005-2015

- Liver cancer, crude incidence rate, males, 2005-2015
- Liver cancer, crude incidence rate, females, 2005-2015

- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, males, 2005-2015
- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, females, 2005-2015

- Pancreas cancer, crude incidence rate, males, 2005-2015
- Pancreas cancer, crude incidence rate, females, 2005-2015

- Larynx cancer, crude incidence rate, males, 2005-2015
- Larynx cancer, crude incidence rate, females, 2005-2015

- Trachea-bronchus-lung cancer, crude incidence rate, males, 2005-2015
- Trachea-bronchus-lung cancer, crude incidence rate, females, 2005-2015

- Bone cancer, crude incidence rate, males, 2005-2015
- Bone cancer, crude incidence rate, females, 2005-2015

- Melanoma, crude incidence rate, males, 2005-2015
- Melanoma, crude incidence rate, females, 2005-2015

- Non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- Non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Mesothelioma, crude incidence rate, males, 2005-2015
- Mesothelioma, crude incidence rate, females, 2005-2015

- Breast cancer, crude incidence rate, males, 2005-2015
- Breast cancer, crude incidence rate, females, 2005-2015

- Col uteri cancer, crude incidence rate, females, 2005-2015
- Corpus uteri cancer, crude incidence rate, females, 2005-2015
- Ovary cancer, crude incidence rate, females, 2005-2015

- Prostate cancer, crude incidence rate, males, 2005-2015
- Testis cancer, crude incidence rate, males, 2005-2015

- Kidney cancer, crude incidence rate, males, 2005-2015
- Kidney cancer, crude incidence rate, females, 2005-2015

- Bladder cancer, crude incidence rate, males, 2005-2015
- Bladder cancer, crude incidence rate, females, 2005-2015

- Brain and central nervous system cancer, crude incidence rate, males, 2005-2015
- Brain and central nervous system cancer, crude incidence rate, females, 2005-2015

- Thyroid cancer, crude incidence rate, males, 2005-2015
- Thyroid cancer, crude incidence rate, females, 2005-2015

- Hodgkin's lymphoma, crude incidence rate, males, 2005-2015
- Hodgkin's lymphoma, crude incidence rate, females, 2005-2015

- Non-Hodgkin lymphoma, crude incidence rate, males, 2005-2015
- Non-Hodgkin lymphoma, crude incidence rate, females, 2005-2015

- Lymphoma all types, crude incidence rate, males, 2005-2015
- Lymphoma all types, crude incidence rate, females, 2005-2015

- Multiple myeloma, crude incidence rate, males, 2005-2015
- Multiple myeloma, crude incidence rate, females, 2005-2015

- Lymphoid leukemia, crude incidence rate, males, 2005-2015
- Lymphoid leukemia, crude incidence rate, females, 2005-2015

- Myeloid leukemia, crude incidence rate, males, 2005-2015
- Myeloid leukemia, crude incidence rate, females, 2005-2015

- Leukemia all types, crude incidence rate, males, 2005-2015
- Leukemia all types, crude incidence rate, females, 2005-2015

 
    ...
    6
ATC Name B/G Ingredients Dosage Form Price
L01FG01 BEVACIREL BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution 14,719,570 L.L
G03DA04 BIOGEST BioTech Progesterone, bio-identical - 100mg/2ml 100mg/2ml Injectable solution 2,328,879 L.L
L03AX03 BCG-MEDAC G BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units Injectable powder for suspension+diluent 18,750,588 L.L
L03AX03 BCG-MEDAC G BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units Injectable powder for suspension+diluent L.L
L01FB01 BESPONSA FOR INJECTION BioTech Inotuzumab Ozogamicin - 0.9mg 0.9mg Injectable powder for suspension L.L
L01FB01 BESPONSA FOR INJECTION BioTech Inotuzumab Ozogamicin - 0.9mg 0.9mg Injectable powder for suspension 921,176,511 L.L
B02BD04 BENEFIX BioTech Nonacog alfa (recombinant coagulation factor IX) - 500IU 500IU Injectable powder for solution+diluent 27,390,281 L.L
B02BD04 BENEFIX BioTech Nonacog alfa (recombinant coagulation factor IX) - 500IU 500IU Injectable powder for solution+diluent L.L
L01XG01 BORTEZOMIB PHARMINICIO G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 13,007,658 L.L
L01XG01 BORTEZOMIB SPC G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 15,743,401 L.L
L01DC01 BLEO-CELL G Bleomycin (sulfate) - 15mg 15mg Injectable powder for solution 3,817,857 L.L
M03AX01 BOTOX BioTech Clostridium botulinum type A neurotoxin complex - 100U 100U Injectable powder for solution 18,625,995 L.L
M03AX01 BOTOX BioTech Clostridium botulinum type A neurotoxin complex - 100U 100U Injectable powder for solution 18,625,995 L.L
L01XG01 BORTEZOMIB ACCORD G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 13,007,658 L.L
L01AA09 BENDAMUSTINE HYDROCHLORIDE G Bendamustine HCl - 25mg/10ml 25mg/10ml Injectable powder for concentrate for solution 19,610,153 L.L
L01AA09 BENDAMUSTINE MEDAC G Bendamustine HCl - 2.5mg/ml (25mg) 2.5mg/ml Injectable powder for concentrate for solution 24,934,922 L.L
L01AA09 BENDAMUSTINE HYDROCHLORIDE G Bendamustine HCl - 100mg/50ml 100mg/50ml Injectable powder for concentrate for solution 78,439,178 L.L
L01AA09 BENDAMUSTINE HYDROCHLORIDE PHARMINICIO G Bendamustine HCl - 100mg/50ml 100mg/50ml Injectable powder for concentrate for solution 78,439,178 L.L
L01AA09 BENDAMUSTINE MEDAC G Bendamustine HCl - 2.5mg/ml (100mg) 2.5mg/ml Injectable powder for concentrate for solution 16,887,989 L.L
L01FX07 BLINCYTO BioTech Blinatumomab - 35mcg 35mcg Injectable lyophilised powder for solution+stabilizer L.L
L01FX07 BLINCYTO BioTech Blinatumomab - 35mcg 35mcg Injectable lyophilised powder for solution+stabilizer 239,484,334 L.L
B02BD02 BERIATE BioHuman Coagulation Factor VIII - 250IU 250IU Injectable lyophilised powder for solution+diluent 14,098,526 L.L
B02BD02 BERIATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent 28,437,886 L.L
L01DC01 BLEOCIN B Bleomycin (sulfate) - 15U 15U Injectable lyophilised powder for solution 2,109,833 L.L
L01XG01 BORTEZOMIB NEAPOLIS G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder for solution L.L
L01XG01 BORTEZOMIB NEAPOLIS G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder for solution 14,169,600 L.L
L01XG01 BORTEZOMIB SHILPA G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder 9,902,420 L.L
L01XG01 BORCADE G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder 11,020,381 L.L
L01XG01 BORCADE G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder 11,020,381 L.L
L01AA09 BENDAVIVAL G Bendamustine HCl - 100mg 100mg Injectable concentrated powder for solution L.L
    ...
    6
Sitemap
© Copyrights reserved to Ministry of Public Health 2025